IMD Prevention in High-Risk Populations: The Role of MenACWY vaccines

CAN-eng

$0

free

Unaccredited

1 hr

Infectious Disease,Rare Diseases,Travel Medicine

0 Credits

Take this Course
LEARN MORE

Course Description

This 60-minute webinar will focus on the epidemiology, burden, and prevention of IMD, particularly in high-risk populations such as travellers, individuals attending mass gatherings, and older adults at risk. The session will highlight the importance of quadrivalent meningococcal conjugate vaccines and their role in preventing IMD in pre-travel consultations and geriatric consultations.

This program has received an unrestricted educational grant or in-kind support from Sanofi.

Course Details

Expiry Date: 2026-05-05
Professions: Physician,Nursing,Pharmacy,Allied Health,Medical Resident,Student,Specialist

Faculty

  • Betty Golightly, RPh
  • Michael Boivin, BSc.Phm.

Accreditation

Learning Objectives

After completion of the webinar participants will be better able to:

  • Describe the epidemiology and burden of invasive meningococcal disease (IMD)
  • Differentiate quadrivalent conjugate meningococcal vaccines
  • Evaluate clinical, safety, and administration data for the latest IMD vaccine (MenACWY-TT), including its immune response benefits and simplified administration
  • Implement appropriate vaccination strategies for travellers and older adults at risk based on the latest evidence and guidelines
Take this Course